These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 27262301)

  • 1. Pretreatment quality of life, performance status and their relation to treatment discontinuation and treatment changes in high-risk breast cancer patients receiving chemotherapy: results from the prospective randomized ADEBAR trial.
    Eichler M; Singer S; Janni W; Harbeck N; Rack B; Augustin D; Wischnik A; Kiechle M; Ettl J; Scholz C; Fink V; Schwentner L
    Breast Cancer; 2017 Mar; 24(2):319-325. PubMed ID: 27262301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Age on Quality of Life in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Comparative Analysis From the Prospective Multicenter Randomized ADEBAR trial.
    Leinert E; Singer S; Janni W; Harbeck N; Weissenbacher T; Rack B; Augustin D; Wischnik A; Kiechle M; Ettl J; Fink V; Schwentner L; Eichler M
    Clin Breast Cancer; 2017 Apr; 17(2):100-106. PubMed ID: 27884722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short term quality of life with epirubicin-fluorouracil-cyclophosphamid (FEC) and sequential epirubicin/cyclophosphamid-docetaxel (EC-DOC) chemotherapy in patients with primary breast cancer - Results from the prospective multi-center randomized ADEBAR trial.
    Schwentner L; Harbeck N; Singer S; Eichler M; Rack B; Forstbauer H; Wischnik A; Scholz C; Huober J; Friedl TW; Weissenbacher T; Härtl K; Kiechle M; Janni W; Fink V
    Breast; 2016 Jun; 27():69-77. PubMed ID: 27054751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose sequential chemotherapy with recombinant granulocyte colony-stimulating factor and repeated stem-cell support for inflammatory breast cancer patients: does impact on quality of life jeopardize feasibility and acceptability of treatment?
    Macquart-Moulin G; Viens P; Palangié T; Bouscary ML; Delozier T; Roché H; Janvier M; Fabbro M; Moatti JP
    J Clin Oncol; 2000 Feb; 18(4):754-64. PubMed ID: 10673516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical performance, toxicity, and quality of life as assessed by the physician and the patient.
    Luoma ML; Hakamies-Blomqvist L; Sjöström J; Mouridsen H; Pluzanska A; Malmström P; Bengtsson NO; Hultborn R; Ostenstaad B; Mjaaland I; Valvere V; Wist E; Baldursson G; Ahigren J; Blomqvist C
    Acta Oncol; 2002; 41(1):44-9. PubMed ID: 11990517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depression and functional impairment independently contribute to decreased quality of life in cancer patients prior to chemotherapy.
    Wedding U; Koch A; Röhrig B; Pientka L; Sauer H; Höffken K; Maurer I
    Acta Oncol; 2008; 47(1):56-62. PubMed ID: 18097778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating patient reported measures as predictive parameters into decisionmaking about palliative chemotherapy: a pilot study.
    Creutzfeldt A; Suling A; Oechsle K; Mehnert A; Atanackovic D; Kripp M; Arnold D; Stein A; Quidde J
    BMC Palliat Care; 2016 Mar; 15():25. PubMed ID: 26928745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deterioration of quality of life of high-risk breast cancer patients treated with high-dose chemotherapy: the PEGASE 01 Quality of Life Study.
    Marino P; Roché H; Biron P; Janvier M; Spaeth D; Fabbro M; Linassier C; Delozier T; Martin AL; Santin G; Moatti JP;
    Value Health; 2008; 11(4):709-18. PubMed ID: 18194401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of health-related quality of life in early discontinuation of chemotherapy for breast cancer.
    Richardson LC; Wang W; Hartzema AG; Wagner S
    Breast J; 2007; 13(6):581-7. PubMed ID: 17983400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic value of WHO performance status in relation to quality of life in advanced colorectal cancer patients.
    Mol L; Ottevanger PB; Koopman M; Punt CJ
    Eur J Cancer; 2016 Oct; 66():138-43. PubMed ID: 27573427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long term effects of extended adjuvant endocrine therapy on quality of life in breast cancer patients.
    Kool M; Fontein DB; Meershoek-Klein Kranenbarg E; Nortier JW; Rutgers EJ; Marang-van de Mheen PJ; van de Velde CJ
    Breast; 2015 Jun; 24(3):224-9. PubMed ID: 25704982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic effects of performance status and quality of life scores on progression-free survival and overall survival in advanced ovarian cancer.
    Carey MS; Bacon M; Tu D; Butler L; Bezjak A; Stuart GC
    Gynecol Oncol; 2008 Jan; 108(1):100-5. PubMed ID: 17920108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-cultural comparison of breast cancer patients' Quality of Life in the Netherlands and Japan.
    Fischer MJ; Inoue K; Matsuda A; Kroep JR; Nagai S; Tozuka K; Momiyama M; Weijl NI; Langemeijer-Bosman D; Ramai SRS; Nortier JWR; Putter H; Yamaoka K; Kubota K; Kobayashi K; Kaptein AA
    Breast Cancer Res Treat; 2017 Nov; 166(2):459-471. PubMed ID: 28762012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life in women with breast cancer during the first year after random assignment to adjuvant treatment with marrow-supported high-dose chemotherapy with cyclophosphamide, thiotepa, and carboplatin or tailored therapy with Fluorouracil, epirubicin, and cyclophosphamide: Scandinavian Breast Group Study 9401.
    Brandberg Y; Michelson H; Nilsson B; Bolund C; Erikstein B; Hietanen P; Kaasa S; Nilsson J; Wiklund T; Wilking N; Bergh J;
    J Clin Oncol; 2003 Oct; 21(19):3659-64. PubMed ID: 14512398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective evaluation of acute toxicity and quality of life after IMRT and concurrent chemotherapy for anal canal and perianal cancer.
    Han K; Cummings BJ; Lindsay P; Skliarenko J; Craig T; Le LW; Brierley J; Wong R; Dinniwell R; Bayley AJ; Dawson LA; Ringash J; Krzyzanowska MK; Moore MJ; Chen EX; Easson AM; Kassam Z; Cho C; Kim J
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):587-94. PubMed ID: 25194664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of the course of quality of life during therapy in women with primary breast cancer.
    Wöckel A; Schwentner L; Krockenberger M; Kreienberg R; Janni W; Wischnewsky M; Thorsten K; Felix F; Riccardo F; Blettner M; Singer S
    Qual Life Res; 2017 Aug; 26(8):2201-2208. PubMed ID: 28386772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variability of patterns of fatigue and quality of life over time based on different breast cancer adjuvant chemotherapy regimens.
    Berger AM; Lockhart K; Agrawal S
    Oncol Nurs Forum; 2009 Sep; 36(5):563-70. PubMed ID: 19726396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group comparing quality of life in patients with ovarian cancer treated with cisplatin/paclitaxel versus carboplatin/paclitaxel.
    Greimel ER; Bjelic-Radisic V; Pfisterer J; Hilpert F; Daghofer F; du Bois A;
    J Clin Oncol; 2006 Feb; 24(4):579-86. PubMed ID: 16446330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life analyses in a clinical trial of DPPE (tesmilifene) plus doxorubicin versus doxorubicin in patients with advanced or metastatic breast cancer: NCIC CTG Trial MA.19.
    Liu J; Tu D; Dancey J; Reyno L; Pritchard KI; Pater J; Seymour LK
    Breast Cancer Res Treat; 2006 Dec; 100(3):263-71. PubMed ID: 16823511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.